Skip to main content

NEOG

Stock
Health Care
Diagnostics & Research

Performance overview

NEOG Price
Price Chart

Forward-looking statistics

Beta
0.81
Risk
43.98%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees2K
Market cap$3.5B

Fundamentals

Enterprise value$1.8B
Revenue$906.0M
Revenue per employee
Profit margin-53.56%
Debt to equity33.61

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.23
Dividend per share
Revenue per share$4.18
Avg trading volume (30 day)$30M
Avg trading volume (10 day)$41M
Put-call ratio

Macro factor sensitivity

Growth+2.4
Credit+4.2
Liquidity-1.8
Inflation-1.0
Commodities+1.1
Interest Rates-1.6

Valuation

Dividend yield0.00%
PEG Ratio9.03
Price to sales1.28
P/E Ratio9.03
Enterprise Value to Revenue1.99
Price to book0.43

Upcoming events

Next earnings dayApril 9, 2025
Next dividend day
Ex. dividend day

News

Neogen Stock Gains Following Strategic Alliance With Syngenta

NEOG inks a new strategic licensing and supply agreement with Syngenta to market and sell the latter's Talon-G and Talon Weatherblok XT rodenticides in the United States and Canada.

Zacks Investment Research (May 20, 2025)
Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns

Neogen Corp. NEOG reported third-quarter 2025 adjusted EPS of 10 cents on Wednesday, down from 12 cents a year ago, missing the consensus of 11 cents.

Benzinga (April 9, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free